Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Dermal absorption

Currently viewing:

Administrative data

Endpoint:
dermal absorption in vitro / ex vivo
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
No data
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Study was not performed according to GLP. An equivalent or similar guideline to OECD 428 is used. Study is reported extensively. Ethyllinalool and linalool are structural homologues which differ only by a methyl-group. Their physical-chemical properties are comparable and available experimental data on same toxicological endpoints, showed identical toxicological properties. Therefore, it is assumed that all toxicological properties are as well comparable and thus read-across is justified.
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2007
Report date:
2007

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 428 (Skin Absorption: In Vitro Method)
Principles of method if other than guideline:
Not relevant
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Linalool
EC Number:
201-134-4
EC Name:
Linalool
Cas Number:
78-70-6
Molecular formula:
C10H18O
IUPAC Name:
3,7-dimethylocta-1,6-dien-3-ol
Details on test material:
Linalool Pure FCC
- Name of test material (as cited in study report): Linalool
- Substance type: Terpenoid alcohol
- Physical state: Liquid (colourless to very pale yellow)

[1,2-14C]Linalool
See "Confidential details on test material"
Radiolabelling:
yes
Remarks:
[1,2-14C]Linalool

Test animals

Species:
human
Strain:
other: Not relevant
Sex:
female
Details on test animals or test system and environmental conditions:
Not relevant

Administration / exposure

Type of coverage:
other: Open and occlusive (greased coverslip to diffusion cell donor chamber)
Vehicle:
other: 70:30 ethanol/water (v/v)
Duration of exposure:
24 hours
Doses:
- Actual doses: 40.2 mg/ml (4.02%)
- Dose volume: 5 ul/cm2 = 201 ug/cm2
No. of animals per group:
12 replicates/condition (open/occlusive) of 7 different donors
Control animals:
yes
Remarks:
one control cell (open, only vehicle), and benzoic acid as reference control
Details on study design:
DOSE PREPARATION
- Method for preparation of dose suspensions: 199.7 mg linalool in 5 ml ethanol/water (70/30 v/v). 0.53 mg labelled linalool added to 2 ml of this solution.

VEHICLE
- Amount(s) applied (volume or weight with unit): 5 ul/cm2 * 1.2 cm2 = 6 ul
- Concentration (if solution): 4.02%
- Purity ethanol: 99.7-100%

REMOVAL OF TEST SUBSTANCE
After 24 hours with dry cotton bud

SAMPLE PREPARATION
- Storage procedure: In tightly sealed vials
- Preparation details: Extraction from media with different solvents (acetonitrile, optisolve for tape strips, methanol)

ANALYSIS
- Method type for identification: Liquid scintillation counting
Details on in vitro test system (if applicable):
SKIN PREPARATION
- Source of skin: 7 different donors
- Type of skin: Breast and abdominal
- Preparative technique: According to accepted method
- Membrane integrity check: Yes, by assessing permeation of tritiated water
- Storage conditions: -20 degrees Celsius

PRINCIPLES OF ASSAY
- Diffusion cell: Franz-type
- Receptor fluid: PBS
- Solubility of test substance in receptor fluid: 1 mg/ml
- Static system: Yes, containing diffusion cell donor and receptor chamber
- Test temperature: 37.0 +/- 0.5 degrees Celsius (skin surface: 32 +/- 1 degrees Celsius)
- Occlusion: Open and closed
- Reference substance(s): Benzoic acid (3.99 mg/ml in 50/50 (v/v) ethanol/water)

Results and discussion

Signs and symptoms of toxicity:
not examined
Remarks:
in vitro study
Dermal irritation:
not examined
Remarks:
in vitro study
Absorption in different matrices:
See field "results including tables and figures"
Total recovery:
- Total recovery (mean +/- SD):
Unoccluded: 8.01 +/- 2.1%
Occluded: 36.3 +/- 10.1%
Control: no radiolabel contamination was detected in any of the compartments
Overall evaporative loss: ~97%
Permeation benzoic acid: 89.6 +/- 3.0%, indicating a valid test system
- Recovery of applied dose acceptable: No, recovery should be 100 +/- 10%
- Results adjusted for incomplete recovery of the applied dose: No, but evaporative loss is determined
Percutaneous absorptionopen allclose all
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 0.7 %
Remarks on result:
other: 0.5 h
Remarks:
Open conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 1.3 %
Remarks on result:
other: 1 h
Remarks:
Open conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 2.7 %
Remarks on result:
other: 6 h
Remarks:
Open conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 2.9 %
Remarks on result:
other: 12 h
Remarks:
Open conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 3 %
Remarks on result:
other: 24 h
Remarks:
Open conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 1.3 %
Remarks on result:
other: 0.5 h
Remarks:
Occluded conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 3.4 %
Remarks on result:
other: 1 h
Remarks:
Occluded conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 10.1 %
Remarks on result:
other: 6 h
Remarks:
Occluded conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 11.7 %
Remarks on result:
other: 12 h
Remarks:
Occluded conditions (excl. epidermis)
Dose:
40.2 mg/ml
Parameter:
percentage
Absorption:
ca. 12.7 %
Remarks on result:
other: 24 h
Remarks:
Occluded conditions (excl. epidermis)
Conversion factor human vs. animal skin:
Not applicable

Any other information on results incl. tables

Distribution of linalool and percentage absorption in different compartments:

Mean (+/- SD) distribution of linalool in all compartments (ug/cm2) (after 24 hours) 24h wipe Donor chamber Strip 1* Strips 2-3 Strips 4-6 Strips 7-10 Epidermis Filter paper Receptor phase
Unoccluded conditions Mean 5.41 2.16 0.399 0.553 0.295 0.172 0.65 0.609 5.95
  SD 1.06 0.9 0.256 0.443 0.164 0.097 0.448 0.191 3.17
Occluded conditions Mean 6.32 36.7 0.317 0.312 0.227 0.161 1.02 2.39 25.6
  SD 1.83 18.1 0.232 0.204 0.13 0.098 0.51 0.71 7.5

* Skin membranes were stripped 10 times and the strips were grouped

Absorption (%) of linalool in all compartments (after 24 hours) 24h wipe Donor chamber Strip 1* Strips 2-3 Strips 4-6 Strips 7-10 Epidermis Filter paper Receptor phase
Unoccluded conditions Mean 2.67 1.07 0.198 0.274 0.146 0.085 0.321 0.301 2.95
  SD 0.52 0.44 0.128 0.221 0.082 0.049 0.223 0.095 1.58
Occluded conditions Mean 3.14 18.2 0.158 0.155 0.113 0.08 0.506 1.19 12.7
  SD 0.91 9.0 0.116 0.101 0.065 0.049 0.253 0.35 3.7

* Skin membranes were stripped 10 times and the strips were grouped

Read across:

Ethyllinalool and linalool are structural homologues which differ only by a methyl-group. Their physical-chemical properties are comparable and available experimental data on same toxicological endpoints, showed identical toxicological properties. Therefore, it is assumed that all toxicological properties are as well comparable and thus read-across is justified. Toxicokinetic data were identified for linalool which was shown to be rapidly and completely absorbed and excreted upon oral administration. Although toxicokinetic data on ethyllinalool were not identified, it can be reasonably assumed that ethyllinalool is absorbed, distributed, metabolized and excreted via the same mechanisms as linalool. This assumption is supported by (i) comparable vapor pressure, water solubility and log Pow and (ii) in silico metabolism prediction for ethyllinalool using computational software METEOR version 12. It is predicted that ethyllinalool may be glucuronidated at the hydroxyl-group and / or hydroxylated at the allylic positions and at the terminal methyl-group with subsequent glucuronidation.

Applicant's summary and conclusion

Conclusions:
Under the conditions of this test, linalool was found to penetrate through human skin. Occlusion of the test system resulted in a higher absorption rate after 24 hours (3.0% after open application versus 12.7% after occlusion). However, a large portion of the applied dose evaporated within 24 hours.
Executive summary:

This study was conducted to determine the skin penetrating potential of linalool. An in vitro diffusion cell test system was used (methods equivalent or similar to OECD guideline 428). Prepared human skin membranes were exposed open and occluded to 40.2 mg/ml (201 ug/cm2, 1.2 cm2 cell) radiolabelled linalool (in 70/30% ethanol/water) for 24 hours and the amount of test substance left on the skin (by wipe), in the donor chamber, stratum corneum (tape strips), epidermis, filter paper and receptor chamber were determined by liquid scintillation counting. One control skin membrane was used (unoccluded) where only the vehicle was added. Evaporation loss was also determined in an additional experiment. A reference substance (benzoic acid) was used to test the validity of the test sytem.

Linalool was found to penetrate through skin and after 24 hours 3.0% of the applied dose was recovered in receptor fluid in the open test system, versus 12.7% in the receptor fluid in the occluded test system. It was found that about 97% of the applied linalool dose evaporated within 24 hours, resulting in a very low total recovery in the open test system. Benzoic acid was found to penetrate rapidly through skin, total recovery was 89.6%. The test system is therefore shown to be valid.

Under the conditions of this test, linalool was found to penetrate through human skin. Occlusion of the test system resulted in a higher absorption rate after 24 hours (3.0% versus 12.7%). However, a large portion (97%) of the applied dose evaporated within 24 hours. Thus, systemic exposure to topically applied linalool is low.